Abstract
Cynicism is an attitude that people are motivated primarily by self-interest, and often manifests alongside emotions like contempt, anger, and hostility. Cynicism can impact all aspects of an individual’s life: in the workplace it is a critical component of burnout, while at home it often leads to marital dissatisfaction and increased family conflicts. Using data from 2,317 participants in the CARDIA Cohort study, we performed a genome-wide association study (GWAS) to identify genetic variants related to cynicism and the cynical distrust sub-trait. We performed two GWAS tests for each trait, one without controlling for population stratification and a second where we considered possible ancestry-related stratification using principal component analysis within plink 1.9. We also tested multiple genetic inheritance models. Finally, we performed pathway analysis using the STRINGdb web resource to identify meaningful relationships. From our various approaches, we identified 12 variants associated with high cynicism in an additive model and 258 in a genotypic model. We also identified 24 and 275 variants associated with cynical distrust using the respective models. Our network analysis revealed clear pathways for how cynicism can lead to health outcomes like cardiovascular disease, adrenal disorders, neurological disorders, and even addiction. Specifically, genes involved in 30 distinct KEGG pathways were related to cynicism and clear connections can be made between cynicism and cardiomyopathies, Cushing syndrome, Alzheimer’s disease, and amphetamine addiction. Each of the outcomes are supported by gene association with at least 3 intermediate pathways. Our results provide the first objective evidence supporting the observational literature connections to cardiovascular disease, Alzheimer’s disease, and addiction. To the best of our knowledge, this is the first evidence presenting a relationship between cynicism and Cushing’s syndrome, demonstrating the power of population and statistical genetics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by WIRB-Copernicus Group IRB (Study number 1332892) and was performed in accordance with the Helsinki declaration.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Genotype and phenotype data that support this study can be obtained from dbGAP using accession numbers phs000285.v3.p2, pht001579.v2.p2, pht001634v2.p2, pht001786.v2.p2, phg000092.v2, and phg000098.v2. GWAS summary statistics are unavailable for public posting, per the CARDIA data use agreement. The lists of significantly associated variants along with P-value and effect sizes are available as supplementary material. Full summary statistics are available from the author upon reasonable request.